Iron levels found in hemochromatosis patients inhibit γ-thrombin-induced platelet aggregation

References

• Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. Diagnosis and management of hemochromatosis: 2011 practice guidelines by the American Association for the study of liver diseases. Hepatology 2011; 54: 328–343, doi: 10.1002/hep.24330 [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R, Jr, Ellis MC, Fullan A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399–408
   PubMed Web of Science ®Google Scholar
• Pietrangelo A. Non-HFE hemochromatosis. Semin Liver Dis 2005; 25: 450–460
   PubMed Web of Science ®Google Scholar
• Carroll GJ, Breidahl WH, Bulsara MK, Olynyk JK. Hereditary hemochromatosis is characterized by a clinically definable arthropathy that correlates with iron load. Arthritis Rheum 2011; 63: 286–294
   PubMed Web of Science ®Google Scholar
• Andrews NC. Disorders of iron metabolism. N Engl J Med 1999; 341: 1986–1995
   PubMed Web of Science ®Google Scholar
• Corradini E, Ferrara F, Pietrangelo A. Iron and the liver. Pediatr Endocrinol Rev 2004; 2(Suppl. 2)245–248
   PubMedGoogle Scholar
• Lefton HB, Rosa A, Cohen M. Diagnosis and epidemiology of cirrhosis. Med Clin North Am 2009; 93: 787–799
   PubMed Web of Science ®Google Scholar
• Huang J, Jones D, Luo B, Sanderson M, Soto J, Abel ED, Cooksey RC, McClain DA. Iron overload and diabetes risk: A shift from glucose to fatty acid oxidation and increased hepatic glucose production in a mouse model of hereditary hemochromatosis. Diabetes 2011; 60: 80–87
   PubMed Web of Science ®Google Scholar
• Steegman-Olmedillas JL. The role of iron in tumour cell proliferation. Clin Transl Oncol 2011; 13: 71–76
   PubMed Web of Science ®Google Scholar
• Onitilo AA, Engel JM, Sajjad SM. The possible role of hemochromatosis in testicular cancer. Med Hypotheses 2011; 77: 179–181 [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Gannon PO, Medelci S, Le Page C, Beaulieu M, Provencher DM, Mes-Masson AM, Santos MM. Impact of hemochromatosis gene (HFE) mutations on epithelial ovarian cancer risk and prognosis. Int J Cancer 2011; 128: 2326–2334
   PubMed Web of Science ®Google Scholar
• Day SM, Duquaine D, Mundada LV, Menon RG, Khan BV, Rajagopalan S, Fay WP. Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation 2003; 107: 2601–2606
   PubMed Web of Science ®Google Scholar
• Murphy CJ, Oudit GY. Iron-overload cardiomyopathy: Pathophysiology, diagnosis, and treatment. J Card Fail 2010; 16: 888–900
   PubMed Web of Science ®Google Scholar
• Angiolillo DJ, Ueno M, Goto S. Basic principles of platelet biology and clinical implications. Circ J 2010; 74: 597–607
   PubMed Web of Science ®Google Scholar
• Soslau G, Goldenberg SJ, Class R, Jameson B. Differential activation and inhibition of human platelet thrombin receptors by structurally distinct alpha-, beta-, and gamma-thrombin. Platelets 2004; 15: 155–166
   PubMed Web of Science ®Google Scholar
• Li Z, Delaney MK, O’Brien KA, Du X. Signaling during platelet adhesion and activation. Arterioscler Thromb Vasc Biol 2010; 30: 2341–2349
   PubMed Web of Science ®Google Scholar
• Azizova OA, Shvachko AG, Aseichev AV. Effect of iron ions on functional activity of thrombin. Bull Exp Biol Med 2009; 148: 776–779
   PubMed Web of Science ®Google Scholar
• Basheer AR, El-Asmar MF, Soslau G. Characterization of a potent platelet aggregation inducer from Cerastes cerastes (Egyptian sand viper) venom. Biochim Biophys Acta 1995; 1250: 97–109
   PubMedGoogle Scholar
• Soslau G, Class R, Morgan DA, Foster C, Lord ST, Marchese P, Ruggeri ZM. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib. J Biol Chem 2001; 276: 21173–21183
   PubMed Web of Science ®Google Scholar
• Bianco C, Brittenham G, Gilcher RO, Gordeuk VR, Kushner JP, Sayers M, Chambers L, Counts RB, Aylesworth C, Nemo G, et al. Maintaining iron balance in women blood donors of childbearing age: Summary of a workshop. Transfusion 2002; 42: 798–805
   PubMedGoogle Scholar
• Kang JO. Chronic iron overload and toxicity: Clinical chemistry perspective. Clin Lab Sci 2001; 14: 209–219
   PubMedGoogle Scholar
• Eaton JW, Qian M. Molecular basis of cellular iron toxicity. Free Radic Biol Med 2002; 32: 833–840
   PubMed Web of Science ®Google Scholar
• Jansen NW, Roosendaal G, Hooiveld MMJ, Bijlsma JWJ, van Roon JAG, Theobald M, Lafeber FPJG. Interleukin-10 protects against blood-induced joint damage. Br J Haematol 2008; 142: 953–961
   PubMed Web of Science ®Google Scholar
• Heiland GR, Aigner E, Dallos T, Sahinbgovic E, Krenn V, Thaler C, Weiss G, Distler JH, Datz C, Schett G, et al. Synovial immunopathology in haemochromatosis arthropathy. Ann Rheum Dis 2010; 69: 1214–1219
   PubMed Web of Science ®Google Scholar